Begin main content

Cancer Drug Pipeline Information

CADTH, through the pCODR program, systematically monitors the cancer drug pipeline — cancer drugs currently under development. CADTH diligently tracks drugs in the pipeline to:

  • identify new cancer drugs and existing cancer drugs proposed for new indications
  • gain awareness of emerging trends in oncology treatment
  • assist provincial drug programs, cancer agencies, and CADTH with proactive health system planning and program operations.

As part of our commitment to transparency, CADTH shares these aggregate results on our website.

The use of this information is intended for informational purposes only by helping to inform the public about anticipated cancer drug products or indications on the horizon. CADTH is not responsible for any errors or omissions, or injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the information or publications on this website or in any of the source documentation. Please refer to our Terms of Use for more details.